Literature DB >> 26195137

Methyl-substitution of an iminohydantoin spiropiperidine β-secretase (BACE-1) inhibitor has a profound effect on its potency.

Melissa Egbertson1, Georgia B McGaughey2, Steven M Pitzenberger3, Shaun R Stauffer4, Craig A Coburn4, Shawn J Stachel4, Wenjin Yang5, James C Barrow4, Lou Anne Neilson4, Melody McWherter4, Debra Perlow4, Bruce Fahr5, Sanjeev Munshi6, Timothy J Allison7, Katharine Holloway2, Harold G Selnick8, ZhiQiang Yang4, John Swestock9, Adam J Simon10, Sethu Sankaranarayanan10, Dennis Colussi10, Katherine Tugusheva10, Ming-Tain Lai10, Beth Pietrak10, Shari Haugabook10, Lixia Jin11, I-W Chen11, Marie Holahan12, Maria Stranieri-Michener12, Jacquelynn J Cook12, Joseph Vacca4, Samuel L Graham4.   

Abstract

The IC50 of a beta-secretase (BACE-1) lead compound was improved ∼200-fold from 11 μM to 55 nM through the addition of a single methyl group. Computational chemistry, small molecule NMR, and protein crystallography capabilities were used to compare the solution conformation of the ligand under varying pH conditions to its conformation when bound in the active site. Chemical modification then explored available binding pockets adjacent to the ligand. A strategically placed methyl group not only maintained the required pKa of the piperidine nitrogen and filled a small hydrophobic pocket, but more importantly, stabilized the conformation best suited for optimized binding to the receptor.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amyloid; Beta secretase; Magic methyl effect; Spiropiperidine

Mesh:

Substances:

Year:  2015        PMID: 26195137     DOI: 10.1016/j.bmcl.2015.06.082

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  Current and emerging therapeutic targets of alzheimer's disease for the design of multi-target directed ligands.

Authors:  Laura Blaikie; Graeme Kay; Paul Kong Thoo Lin
Journal:  Medchemcomm       Date:  2019-10-16       Impact factor: 3.597

2.  Rapid assessment of conformational preferences in biaryl and aryl carbonyl fragments.

Authors:  Sonia Maria Gutiérrez Sanfeliciano; John M Schaus
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

Review 3.  Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment.

Authors:  Judite R M Coimbra; Daniela F F Marques; Salete J Baptista; Cláudia M F Pereira; Paula I Moreira; Teresa C P Dinis; Armanda E Santos; Jorge A R Salvador
Journal:  Front Chem       Date:  2018-05-24       Impact factor: 5.221

4.  Multienzyme One-Pot Cascades Incorporating Methyltransferases for the Strategic Diversification of Tetrahydroisoquinoline Alkaloids.

Authors:  Fabiana Subrizi; Yu Wang; Benjamin Thair; Daniel Méndez-Sánchez; Rebecca Roddan; Max Cárdenas-Fernández; Jutta Siegrist; Michael Richter; Jennifer N Andexer; John M Ward; Helen C Hailes
Journal:  Angew Chem Int Ed Engl       Date:  2021-07-16       Impact factor: 16.823

5.  Hydantoin-bridged medium ring scaffolds by migratory insertion of urea-tethered nitrile anions into aromatic C-N bonds.

Authors:  Makenzie J Millward; Emily Ellis; John W Ward; Jonathan Clayden
Journal:  Chem Sci       Date:  2020-12-14       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.